Skip to main content

Table 1 Comparison of the clinical manifestations of ATTR and COVID-19

From: ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable

 

ATTR

COVID-19

References

Cardiovascular

HF, rhythm disturbances, conduction block, dyspnea, syncope, palpitations, elevated biomarkers, thromboembolism

HF, myocardial injury, myocarditis, acute coronary syndromes, palpitations, dyspnea, elevated biomarkers, thromboembolism

[11, 14, 17, 26, 30, 63, 64, 66]

Gastrointestinal

Diarrhea, constipation, loss of appetite, nausea

Diarrhea, loss of appetite, nausea/vomiting, gastroenteritis

[6, 9, 26, 29, 91, 92]

Hematologic and Immunologic

Increased pro-inflammatory cytokines, increased propensity to left atrial thrombosis

Cytokine storm, venous thrombosis, lymphopenia, venous/arterial thromboembolism, coagulopathy, microangiopathy

[15, 16, 20,21,22, 40, 56]

Musculoskeletal

CTS, spinal stenosis, trigger finger, shoulder, knee and hip surgery

Arthralgia, myalgias

[11, 31, 81, 103, 104]

Renal

Proteinuria, renal failure

AKI, ATN

[26, 30, 40, 48, 93, 94]

Neurologic

 CNS: headache, ataxia, seizures, stroke-like episodes

Headache, dizziness, seizures, mental status changes, muscle pain, stroke, neuropathy (eg, AIDP), myopathy, myelitis, anosmia, hypogeusia, dysgeusia

[12, 26, 30, 32, 34, 70,71,72, 75,76,77, 105, 106]

 Peripheral neuropathy: numbness/tingling in hands and feet, neuropathic pain, walking disability, loss of balance

Autonomic neuropathy: urinary retention and incontinence; erectile dysfunction; orthostatic hypotension; gastrointestinal manifestations

Pulmonary

 Impairment from alveolar-septal amyloidosis

Cough, shortness of breath, pneumonia, ARDS

[1, 4, 5, 44, 45, 47, 48]

 Pulmonary hypertension due to left-sided heart disease

Other/Constitutional

Unintentional weight loss

Fever, fatigue

[5, 7, 26]

  1. Bold text indicates overlapping manifestations or symptoms when comparing ATTR and COVID-19. Cardiac and musculoskeletal manifestations are most predominant in patients with ATTRwt amyloidosis; clinical manifestations in peripheral and autonomic nerves, along with the kidney, and eye are rarer. AIDP Acute Inflammatory Demyelinating Polyneuropathy, AKI Acute kidney injury, ARDS Acute respiratory distress syndrome, ATN Acute tubular necrosis, ATTR Amyloid transthyretin, CNS Central nervous system, COVID-19 Coronavirus disease 2019, CTS Carpal tunnel syndrome, HF Heart failure